reported that severe and long COVID-19 cases exhibit STING and cGAS pathway activation, coinciding with increased IFN-α expression, suggesting a role beyond acute viral clearance and a potential contribution to disease progression (Queiroz et al., 2024). This evidence concerns the gene IFNA17 and COVID-19.